| Literature DB >> 31169251 |
Nebi Serkan Demirci1, Gokmen Umut Erdem1, Nil İrem Uçgun2, Yakup Bozkaya1, Nuriye Yildirim Ozdemir1, Mutlu Dogan1, Nurullah Zengin1.
Abstract
Tamoxifen-induced ocular complications including cataracts, keratopathies, retinopathy, impaired visual acuity, ocular irritation, optical neuritis, and retinal vein occlusion are uncommonly reported in the literature. Herein, we report on a premenopausal patient with right-side breast carcinoma who received adjuvant tamoxifen therapy (20 mg/day) for 1.5 years and developed sudden visual loss. Fundal examination revealed an obstruction in the branch of the retinal vein. The diagnosis was confirmed by fluorescein angiography and optical coherence tomography. Thus, tamoxifen was switched to an aromatase inhibitor. Tamoxifen-induced ocular complications should be kept in mind when visual symptoms are seen in patients undergoing tamoxifen therapy. In such cases, a complete ocular examination should be performed.Entities:
Keywords: Breast cancer; ocular toxicity; retinal vein occlusion; tamoxifen therapy
Mesh:
Substances:
Year: 2019 PMID: 31169251 DOI: 10.4103/0973-1482.204888
Source DB: PubMed Journal: J Cancer Res Ther ISSN: 1998-4138 Impact factor: 1.805